EndNote X8 is Here

EndNote X8 is available for download on Machias. For more information about installing EndNote X8 please phone us at (215) 728-2711 or consult our EndNote Libguide. EndNote is not difficult to install yourself, but it is a two-step process. First, you need to install the installer and then you install the program. If you have an earlier version of EndNote installed please create backup copies of your libraries and then uninstall whatever version you have before installing X8.

Here is what’s new in EndNote X8

  1. Share your library with up to 100 other EndNote desktop users on X7.2 or later; providing teams with immediate real time access to the same set of references, attachments, notes and annotations.
  2. Access the Activity Feed to see what your colleagues are doing in the Shared Library and when new members join.
  3. New, modern, easy to identify icons – identical across both Mac and Windows.
  4. Updated workflows for finding reference updates.
  5. Every X8 library includes a built in Recently Added group which can be customized, allowing users to pick up right where they left off in the research workflow.
  6. Configure Sync option in the Groups pane to simplify desktop activation process.
  7. Utilize unlimited file attachment storage in your online library.
  8. Cite While You Write for Microsoft Word 2016.

We at the library are being trained on some of the new features including the improved sharing features. We will be sharing our knowledge with you.


Staff Publications – December 2016

1. Abdel-Misih SR, Wei L, Benson AB, 3rd, et al. Neoadjuvant Therapy for Rectal Cancer Affects Lymph Node Yield and Status without Clear Implications on Outcome: The Case for Eliminating a Metric and Using Preoperative Staging to Guide Therapy. Journal of the National Comprehensive Cancer Network : JNCCN. 2016;14(12):1528-1534. PMID: 27956537.

2. Acquati C, Reese JB, Karam E, Kayser K, Mark K, Wittmann D. A Systematic Review of Dyadic Studies Examining Relationship Quality in Couples Facing Colorectal Cancer Together. Psycho-oncology. 2016. PMID: 27943551.

3. Antonia SJ, Gettinger SN, Goldman J, et al. Oral01.03: Checkmate 012: Safety and Efficacy of First-Line Nivolumab and Ipilimumab in Advanced Nsclc: Topic: Medical Oncology. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2016;11(11s):S250-s251. PMID: 27969442.

4. Berger ER, Wang CE, Kaufman CS, et al. National Accreditation Program for Breast Centers Accreditation Demonstrates Improved Compliance with Post-Mastectomy Radiation Therapy Quality Measure. Journal of the American College of Surgeons. 2016. PMID: 27993697.

5. Cahn DB, Ristau BT, Uzzo RG, Smaldone MC. Morbidity and Mortality of Radical Nephrectomy for Patients with Disseminated Cancer: An Analysis of the National Surgical Quality Improvement Program Database. Urology. 2016;95:101-102.

6. Camacho-Rivera M, Ragin C, Roach V, Kalwar T, Taioli E. Breast Cancer Clinical Characteristics and Outcomes in Trinidad and Tobago. Journal of immigrant and minority health. 2015;17(3):765-772. PMID: 24146313.

7. Chang EI, Bradley JP. Reply: Long-Term Operative Outcomes of Preoperative Computed Tomography-Guided Virtual Surgical Planning for Osteocutaneous Free Flap Mandible Reconstruction. Plastic and Reconstructive Surgery. 2016;138(4):775E-775E.

8. Chen RW, Li H, Bernstein SH, et al. Rb but Not R-Hcvad Is a Feasible Induction Regimen Prior to Auto-Hct in Frontline Mcl: Results of Swog Study S1106. British journal of haematology. 2016. PMID: 27992063.

9. Chera B, Wang K, Monroe A, et al. Truth or Myth: Definitive Chemoradiotherapy Doesn’t Work for Hpv/P16 Negative Oropharyngeal Squamous Cell Carcinoma? Oral oncology. 2016. PMID: 27993466.

10. Chwistek M. Winter Morning. Annals of internal medicine. 2016;165(12):886. PMID: 27992913.

11. Consedine NS, Tuck NL, Ragin CR, Spencer BA. Beyond the Black Box: A Systematic Review of Breast, Prostate, Colorectal, and Cervical Screening among Native and Immigrant African-Descent Caribbean Populations. Journal of immigrant and minority health. 2015;17(3):905-924. PMID: 24522436.

12. Correa AF, Kutikov A. Editorial Comment. Urology. 2016. PMID: 28034531.

13. Cruz OV, Prudnikova TY, Araiza-Olivera D, et al. Reduced Pak1 Activity Sensitizes Fa/Brca-Proficient Breast Cancer Cells to Parp Inhibition. Oncotarget. 2016;7(47):76590-76603.

14. Daly MB, Pilarski R, Berry M, et al. Nccn Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017. Journal of the National Comprehensive Cancer Network : JNCCN. 2017;15(1):9-20. PMID: 28040716.

15. Doss M. Changing the Paradigm of Cancer Screening, Prevention, and Treatment. Dose-response : a publication of International Hormesis Society. 2016;14(4):1559325816680539. PMID: 27928220. PMCID: PMC5134297.

16. Esselen KM, Cronin AM, Bixel K, et al. Use of Ca-125 Tests and Computed Tomographic Scans for Surveillance in Ovarian Cancer. Obstetrical and Gynecological Survey. 2016;71(11):660-661.

17. Ettinger DS, Wood DE, Akerley W, et al. Nccn Guidelines Insights: Non-Small Cell Lung Cancer, Version 4.2016. Journal of the National Comprehensive Cancer Network : JNCCN. 2016;14(3):255-264. PMID: 26957612.
18. Fatkhullina AR, Peshkova IO, Koltsova EK. The Role of Cytokines in the Development of Atherosclerosis. Biochemistry-Moscow. 2016;81(11):1358-1370. PMID: WOS:000388960400013.
19. Flynn KE, Carter J, Lin L, et al. Assessment of Vulvar Discomfort with Sexual Activity among Women in the United States. American journal of obstetrics and gynecology. 2016. PMID: 27988269.

20. Fuletra JG, Ristau BT, Milestone B, et al. Angiosarcoma of the Adrenal Gland Treated Using a Multimodal Approach. Urology case reports. 2017;10:38-41. PMID: 27920990. PMICD: PMC5137173.

21. Ghiraldi E, Reddy M, Li T, Lawler AC, Friedlander J. Factors Associated with Compliance in Submitting 24-Hour Urine Collections in an Underserved Community. Journal of endourology. 2016. PMID: 27931114.

22. Golan S, Johnson S, Maurice M, et al. Safety and Early Effectiveness of Robotic Partial Nephrectomy for Large Angiomyolipomas. BJU international. 2016. PMID: 27988984.

23. Guha M, Srinivasan S, Guja K, et al. Hnrnpa2 Is a Novel Histone Acetyltransferase That Mediates Mitochondrial Stress-Induced Nuclear Gene Expression. Cell discovery. 2016;2:16045. PMID: 27990297. PMC5148442.

24. Haber AD. The Law of Unintended Consequences. Annals of internal medicine. 2016;165(11):824-825. PMID: 27919093.

25. Hahn NM, Bivalacqua TJ, Ross AE, et al. A Phase Ii Trial of Dovitinib in Bcg-Unresponsive Urothelial Carcinoma with Fgfr3 Mutations or over-Expression: Hoosier Cancer Research Network Trial Hcrn 12-157. Clinical cancer research : an official journal of the American Association for Cancer Research. 2016. PMID: 27932416.

26. Haifler M, Mor Y, Dotan Z, Ramon J, Zilberman DE. Prophylactic Antibiotic Treatment Following Laparoscopic Robot-Assisted Radical Prostatectomy for the Prevention of Catheter-Associated Urinary Tract Infections: Did the Aua Guidelines Make a Difference? Journal of robotic surgery. 2016. PMID: 27987067.

27. Hellmann MD, Rizvi NA, Goldman JW, et al. Nivolumab Plus Ipilimumab as First-Line Treatment for Advanced Non-Small-Cell Lung Cancer (Checkmate 012): Results of an Open-Label, Phase 1, Multicohort Study. The Lancet Oncology. 2016. PMID: 27932067.

28. Henry RA, Mancuso P, Kuo YM, et al. Interaction with the DNA Repair Protein Thymine DNA Glycosylase Regulates Histone Acetylation by P300. Biochemistry. 2016;55(49):6766-6775. PMID: 27951654.

29. Huang JF, Zhang FZ, Zou QZ, et al. Induction Chemotherapy Followed by Concurrent Chemoradiation and Nimotuzumab for Locoregionally Advanced Nasopharyngeal Carcinoma: Preliminary Results from a Phase Ii Clinical Trial. Oncotarget. 2016. PMID: 27974693.

30. Johnson ME, Zaorsky NG, Martin JM, et al. Patient Reported Outcomes among Treatment Modalities for Prostate Cancer. The Canadian journal of urology. 2016;23(6):8535-8545. PMID: 27995848.

31. Johnson SF, Cruz C, Greifenberg AK, et al. Cdk12 Inhibition Reverses De Novo and Acquired Parp Inhibitor Resistance in Brca Wild-Type and Mutated Models of Triple-Negative Breast Cancer. Cell Reports. 2016;17(9):2367-2381.

32. Joseph GA, Lu M, Radu M, et al. Group I Paks Promote Skeletal Myoblast Differentiation in Vivo and in Vitro. Molecular and cellular biology. 2016. PMID: 27920252.

33. Judd J, Dulaimi E, Li T, et al. Low Level of Blood Cd4+ T Cells Is an Independent Predictor of Inferior Progression-Free Survival in Diffuse Large B-Cell Lymphoma. Clinical lymphoma, myeloma & leukemia. 2016. PMID: 28027895.

34. Jung K, Ghatalia P, Litwin S, et al. Small-Cell Carcinoma of the Bladder: 20-Year Single-Institution Retrospective Review. Clinical genitourinary cancer. 2016. PMID: 27991416.

35. Kim SP, Campbell SC, Gill I, et al. Collaborative Review of Risk Benefit Trade-Offs between Partial and Radical Nephrectomy in the Management of Anatomically Complex Renal Masses. European urology. 2016. PMID: 27988238.

36. Malhotra S, Karanicolas J. When Does Chemical Elaboration Induce a Ligand to Change Its Binding Mode? Journal of medicinal chemistry. 2016. PMID: 27982595.

37. Manne SL, Myers-Virtue S, Darabos K, et al. Emotional Processing During Psychotherapy among Women Newly Diagnosed with a Gynecological Cancer. Palliative & supportive care. 2016:1-12. PMID: 27964770.

38. Mookerjee-Basu J, Kappes DJ. Inkt Cells Do a Fat Lot of Good. Nature immunology. 2016;18(1):10-12. PMID: 27984570.

39. Moore KN, Martin LP, O’Malley DM, et al. Safety and Activity of Mirvetuximab Soravtansine (Imgn853), a Folate Receptor Alpha-Targeting Antibody-Drug Conjugate, in Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer: A Phase I Expansion Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2016:Jco2016699538. PMID: 28029313.

40. Newman LA, Stark A, Chitale D, et al. Association between Benign Breast Disease in African American and White American Women and Subsequent Triple-Negative Breast Cancer. JAMA oncology. 2016. PMID: 28006062.

41. Nizovtseva EV, Clauvelin N, Todolli S, et al. Nucleosome-Free DNA Regions Differentially Affect Distant Communication in Chromatin. Nucleic acids research. 2016. PMID: 27940560.

42. Pallera A, Altman JK, Berman E, et al. Nccn Guidelines Insights: Chronic Myeloid Leukemia, Version 1.2017. Journal of the National Comprehensive Cancer Network : JNCCN. 2016;14(12):1505-1512. PMID: 27956535.

43. Punwani D, Zhang Y, Yu J, et al. Multisystem Anomalies in Severe Combined Immunodeficiency with Mutant Bcl11b. The New England journal of medicine. 2016;375(22):2165-2176. PMID: 27959755.

44. Ragin C, Liu JC, Jones G, et al. Prevalence of Hpv Infection in Racial-Ethnic Subgroups of Head and Neck Cancer Patients. Carcinogenesis. 2016. PMID: 28025390.

45. Raje NS, Faber EA, Richardson PG, et al. Phase 1 Study of Tabalumab, a Human Anti-B-Cell Activating Factor Antibody, and Bortezomib in Patients with Relapsed/Refractory Multiple Myeloma. Clinical Cancer Research. 2016;22(23):5688-5695.

46. Ramakodi MP, Devarajan K, Blackman E, et al. Integrative Genomic Analysis Identifies Ancestry-Related Expression Quantitative Trait Loci on DNA Polymerase Β and Supports the Association of Genetic Ancestry with Survival Disparities in Head and Neck Squamous Cell Carcinoma. Cancer. 2016.

47. Ramos JD, Casey MF, Crabb SJ, et al. Venous Thromboembolism in Metastatic Urothelial Carcinoma or Variant Histologies: Incidence, Associative Factors, and Effect on Survival. Cancer medicine. 2016. PMID: 28000388.

48. Rimm D, Han G, Taube JM, et al. Oral01.01: A Prospective, Multi-Institutional Assessment of Four Assays for Pd-L1 Expression in Nsclc by Immunohistochemistry: Topic: Pathology. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2016;11(11s):S249. PMID: 27969440.

49. Rose TL, Deal AM, Ladoire S, et al. Patterns of Bladder Preservation Therapy Utilization for Muscle-Invasive Bladder Cancer. Bladder cancer (Amsterdam, Netherlands). 2016;2(4):405-413. PMID: 28035321. PMC5181658.

50. Shaw AT, Spigel DR, Tan DS, et al. Mini01.01: Whole Body and Intracranial Efficacy of Ceritinib in Alk-Inhibitor Naive Patients with Alk+ Nsclc and Brain Metastases: Results of Ascend 1 and 3: Topic: Medical Oncology. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2016;11(11s):S256. PMID: 27969450.

51. Shi E, Chmielecki J, Tang CM, et al. Fgfr1 and Ntrk3 Actionable Alterations in “Wild-Type” Gastrointestinal Stromal Tumors. Journal of translational medicine. 2016;14(1):339. PMID: 27974047. PMC5157084.

52. Siddiqui F, Smith RV, Yom SS, et al. Acr Appropriateness Criteria(R) Nasal Cavity and Paranasal Sinus Cancers. Head & neck. 2016. PMID: 28032679.

53. Thunnissen E, Borczuk AC, Flieder DB, et al. The Use of Immunohistochemistry Improves the Diagnosis of Small Cell Lung Cancer and Its Differential Diagnosis. An International Reproducibility Study in a Demanding Set of Cases. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2016. PMID: 27998793.

54. Volokh OI, Derkacheva NI, Studitsky VM, Sokolova OS. Structural Studies of Chromatin Remodeling Factors. Molecular Biology. 2016;50(6):812-822.

55. Voss MH, Bhatt RS, Plimack ER, et al. The Dart Study: Results from the Dose-Escalation and Expansion Cohorts Evaluating the Combination of Dalantercept Plus Axitinib in Advanced Renal Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research. 2016. PMID: 28031424.

56. Wang EH, Yu JB, Abouassally R, et al. Disparities in Treatment of Patients with High-Risk Prostate Cancer: Results from a Population-Based Cohort. Urology. 2016;95:88-94.

57. Weidhaas JB, Harris J, Schaue D, et al. The Kras-Variant and Cetuximab Response in Head and Neck Squamous Cell Cancer: A Secondary Analysis of a Randomized Clinical Trial. JAMA oncology. 2016. PMID: 28006059.

58. Weldon CB, Madenci AL, Boikos SA, et al. Surgical Management of Wild-Type Gastrointestinal Stromal Tumors: A Report from the National Institutes of Health Pediatric and Wildtype Gist Clinic. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2016:Jco2016686733. PMID: 28029307.

59. Zendejas B, Jakub JW, Terando AM, et al. Laparoscopic Skill Assessment of Practicing Surgeons Prior to Enrollment in a Surgical Trial of a New Laparoscopic Procedure. Surgical endoscopy. 2016. PMID: 27928664.

Staff Publications-November 2016

1.    Balasubramanian S, Rajagopalan M, Bojja RS, Skalka AM, Andrake MD, Ramaswamy A. The conformational feasibility for the formation of reaching dimer in ASV and HIV integrase: a molecular dynamics study. Journal of biomolecular structure & dynamics. 2016:1-17 PMID: 27835934.

2.    Bansal P, Osman D, Gan GN, Simon GR, Boumber Y. Recent Advances in Immunotherapy in Metastatic NSCLC. Frontiers in oncology. 2016;6:239 PMID: 27896216.

3.    Barta SK, Li HL, Hochster HS, et al. Randomized Phase 3 Study in Low-Grade Lymphoma Comparing Maintenance Anti-CD20 Antibody With Observation After Induction Therapy: A Trial of the ECOG-ACRIN Cancer Research Group (E1496). Cancer. 2016;122(19):2996-3004.

4.    Beck TN, Smith CH, Flieder DB, et al. Head and neck squamous cell carcinoma: Ambiguous human papillomavirus status, elevated p16, and deleted retinoblastoma 1. Head & neck. 2016 PMID: 27859938.

5.    Chang HW, Pandey M, Kulaeva OI, Patel SS, Studitsky VM. Overcoming a nucleosomal barrier to replication. Science advances. 2016;2(11):e1601865 PMID: 27847876. PMCID: PMC5106197.

6.    Cornell RF, D’Souza A, Kassim AA, et al. Maintenance Versus Induction Therapy Choice on Outcomes after Autologous Transplantation for Multiple Myeloma. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2016 PMID: 27864161.

7.    Costa LJ, Maddocks K, Epperla N, et al. Diffuse Large B-Cell Lymphoma with Primary Treatment Failure: Ultra-high Risk Features and Benchmarking for Experimental Therapies. American journal of hematology. 2016 PMID: 27880984.

8.    Fahl SP, Wang M, Zhang Y, Duc AC, Wiest DL. Regulatory Roles of Rpl22 in Hematopoiesis: An Old Dog with New Tricks. Critical reviews in immunology. 2015;35(5):379-400 PMID: 26853850. PMCID: PMC5111805.

9.    Fang CY, Ma GX, Handorf EA, et al. Addressing multilevel barriers to cervical cancer screening in Korean American women: A randomized trial of a community-based intervention. Cancer. 2016 PMID: 27869293.

10.    Gaponova AV, Deneka AY, Beck TN, et al. Identification of evolutionarily conserved DNA damage response genes that alter sensitivity to cisplatin. Oncotarget. 2016 PMID: 27863405.

11.    Garrigan C, Han J, Tolomeo P, et al. Evaluation of a research use only luminex based assay for measurement of procalcitonin in serum samples. American journal of translational research. 2016;8(10):4362-4369 PMID: 27830020. PMCID: PMC5095329.
12.    Gopas J, Stern E, Zurgil U, et al. Reed-Sternberg cells in Hodgkin’s lymphoma present features of cellular senescence. Cell death & disease. 2016;7(11):e2457 PMID: 27831553.

13.    Jiang W, Dulaimi E, Devarajan K, et al. Immunohistochemistry Successfully Uncovers Intratumoral Heterogeneity and Widespread Co-Losses of Chromatin Regulators in Clear Cell Renal Cell Carcinoma. Plos One. 2016;11(10).

14.    Jochems C, Hodge JW, Fantini M, et al. An NK cell line (haNK) expressing high levels of granzyme and engineered to express the high affinity CD16 allele. Oncotarget. 2016 PMID: 27861156.

15.    Johnson SF, Cruz C, Greifenberg AK, et al. CDK12 Inhibition Reverses De Novo and Acquired PARP Inhibitor Resistance in BRCA Wild-Type and Mutated Models of Triple-Negative Breast Cancer. Cell reports. 2016;17(9):2367-2381 PMID: 27880910.

16.    Joshi S, Kutikov A. Editorial Comment. The Journal of urology. 2016 PMID: 27821261.

17.    Joshi SS, Chen DY. Editorial Comment. The Journal of urology. 2016 PMID: 27836456.

18.    Jung K, Zeng X, Bilusic M. Nivolumab-associated acute glomerulonephritis: a case report and literature review. BMC nephrology. 2016;17(1):188 PMID: 27876011. PMCID: PMC5120473.

19.    Li JG, Barrero C, Gupta S, Kruger WD, Merali S, Pratico D. Homocysteine modulates 5-lipoxygenase expression level via DNA methylation. Aging cell. 2016 PMID: 27896923.

20.    Manne SL, Kashy D, Siegel SD, Heckman CJ. Group therapy processes and treatment outcomes in two couple-focused group interventions for breast cancer patients. Psycho-oncology. 2016 PMID: 27885746.

21.    Manne SL, Myers-Virtue S, Kashy DA, et al. Therapy Processes, Progress, and Outcomes for Two Therapies for Gynecological Cancer Patients. Psycho-oncology. 2016 PMID: 27870116.

22.    Manne SL, Virtue SM, Ozga M, et al. A comparison of two psychological interventions for newly-diagnosed gynecological cancer patients. Gynecologic oncology. 2016 PMID: 27887806.

23.    Miller KD, Schnell MJ, Rall GF. Keeping it in check: chronic viral infection and antiviral immunity in the brain. Nature reviews Neuroscience. 2016;17(12):766-776 PMID: 27811921.

24.    Pinheiro PS, Callahan KE, Ragin C, Hage RW, Hylton T, Kobetz EN. Black Heterogeneity in Cancer Mortality: US-Blacks, Haitians, and Jamaicans. Cancer control : journal of the Moffitt Cancer Center. 2016;23(4):347-358 PMID: 27842324.

25.    Rebbeck TR, Friebel TM, Mitra N, et al. Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women. Breast cancer research : BCR. 2016;18(1):112 PMID: 27836010, PMCID: PMC5106833.

26.    Reese JB, Sorice K, Beach MC, et al. Patient-provider communication about sexual concerns in cancer: a systematic review. Journal of cancer survivorship : research and practice. 2016 PMID: 27858322.

27.    Rice TW, Lerut T, Orringer MB, et al. Worldwide Esophageal Cancer Collaboration: neoadjuvant pathologic staging data. Diseases of the Esophagus. 2016;29(7):715-723.

28.    Sato T, Cesaroni M, Chung W, et al. Transcriptional Selectivity of Epigenetic Therapy in Cancer. Cancer research. 2016 PMID: 27879268.

29.    Shah AY, Karam JA, Malouf GG, et al. Management and Outcomes of Patients with Renal Medullary Carcinoma: A Multi-Center Collaborative Study. BJU international. 2016 PMID: 27860149.

30.    Shaikh T, Handorf EA, Murphy CT, Mehra R, Ridge JA, Galloway TJ. The Impact of Radiation Treatment Time on Survival in Patients With Head and Neck Cancer. International journal of radiation oncology, biology, physics. 2016;96(5):967-975 PMID: 27869097.

31.    Shields PG, Herbst RS, Arenberg D, et al. Smoking Cessation, Version 1.2016 Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network. 2016;14(11):1430-1468.

32.    Siminoff LA, Traino HM, Mosavel M, Barker L, Gudger G, Undale A. Family decision maker perspectives on the return of genetic results in biobanking research. Genetics in medicine : official journal of the American College of Medical Genetics. 2016;18(1):82-88 PMID: 25856669. PMCID: PMC4600004.

33.    Smaldone MC, Egleston B, Hollingsworth JM, et al. Understanding Treatment Disconnect and Mortality Trends in Renal Cell Carcinoma Using Tumor Registry Data. Medical care. 2016 PMID: 27820596.

34.    Smith A, Handorf E, Arjmand E, Lango MN. Predictors of regional Medicare expenditures for otolaryngology physician services. The Laryngoscope. 2016 PMID: 27859299.

35.    Stabler CT, Lecht S, Lazarovici P, Lelkes PI. Mesenchymal stem cells for therapeutic applications in pulmonary medicine. British medical bulletin. 2015;115(1):45-56 PMID: 26063231.

36.    Steen HC, Kotredes KP, Nogusa S, Harris MY, Balachandran S, Gamero AM. Phosphorylation of STAT2 on serine-734 negatively regulates the IFN-alpha-induced antiviral response. Journal of cell science. 2016;129(22):4190-4199 PMID: 27802159.

37.    Sturgeon KM, Dean LT, Heroux M, et al. Commercially available lifestyle modification program: randomized controlled trial addressing heart and bone health in BRCA1/2+ breast cancer survivors after risk-reducing salpingo-oophorectomy. Journal of cancer survivorship : research and practice. 2016 PMID: 27873046.

38.    Thapa RJ, Ingram JP, Ragan KB, et al. DAI Senses Influenza A Virus Genomic RNA and Activates RIPK3-Dependent Cell Death. Cell Host and Microbe. 2016;20(5):674-681.

39.    Turner RM, 2nd, Yecies TS, Yabes JG, et al. Biopsy Perineural Invasion in Prostate Cancer Patients Who are Candidates for Active Surveillance by Strict and Expanded Criteria. Urology. 2016 PMID: 27864108.

40.    Valieva ME, Armeev GA, Kudryashova KS, et al. Large-scale ATP-independent nucleosome unfolding by a histone chaperone. Nature structural & molecular biology. 2016 PMID: 27820806.

41.    Van Cleave JH, Egleston BL, Abbott KM, Hirschman KB, Rao A, Naylor MD. Multiple Chronic Conditions and Hospitalizations Among Recipients of Long-Term Services and Supports. Nursing research. 2016;65(6):425-434 PMID: 27801713.

42.    VanderWalde N, Jagsi R, Dotan E, et al. NCCN Guidelines Insights: Older Adult Oncology, Version 2.2016. Journal of the National Comprehensive Cancer Network : JNCCN. 2016;14(11):1357-1370 PMID: 27799507.

43.    Wen KY, Miller SM, Roussi P, et al. A content analysis of self-reported barriers and facilitators to preventing postpartum smoking relapse among a sample of current and former smokers in an underserved population. Health education research. 2015;30(1):140-151 PMID: 25099776. PMCID: PMC4296888.

44.    Zaorsky NG, Churilla TM, Egleston BL, et al. Causes of death among cancer patients. Annals of oncology : official journal of the European Society for Medical Oncology. 2016 PMID: 27831506.

45.    Zhang BW, Xia J, Tan Z, Levy RM. A Stochastic Solution to the Unbinned WHAM Equations. The journal of physical chemistry letters. 2015;6(19):3834-3840 PMID: 26722879, PMCID: PMC4894662.

46.    Zhao YZ, Zhang M, Wong HL, et al. Prevent diabetic cardiomyopathy in diabetic rats by combined therapy of aFGF-loaded nanoparticles and ultrasound-targeted microbubble destruction technique. Journal of controlled release : official journal of the Controlled Release Society. 2016;223:11-21 PMID: 26712588.

47.    Zhou C, Martinez E, Di Marcantonio D, et al. JUN is a key transcriptional regulator of the unfolded protein response in acute myeloid leukemia. Leukemia. 2016 PMID: 27840425.

48.    Zibelman M, Ramamurthy C, Plimack ER. Emerging role of immunotherapy in urothelial carcinoma-Advanced disease. Urologic oncology. 2016;34(12):538-547 PMID: 27888981.

Staff Publications: October 2016

1. Abbosh PH, Rosenberg JE, Plimack ER. Circulating biomarkers to guide systemic therapy for urothelial carcinoma. Urologic oncology. 2016 PMID: 27751785.

2. Ajani JA, D’Amico TA, Almhanna K, et al. Gastric Cancer, Version 3.2016; Clinical Practice Guidelines in Oncology. JNCCN Journal of the National Comprehensive Cancer Network. 2016;14(10):1286-1312.

3. Andrake MD, Skalka AM. Retroviral Integrase: Then and Now. Annual review of virology. 2015;2(1):241-264 PMID: 26958915, PMC4810031.

4. Barbosa Vendramini-Costa D, Francescone R, Posocco D, et al. Anti-inflammatory natural product goniothalamin reduces colitis-associated and sporadic colorectal tumorigenesis. Carcinogenesis. 2016 PMID: 27797827

5. Beitler JJ, Quon H, Jones CU, et al. ACR Appropriateness Criteria (R) Locoregional therapy for resectable oropharyngeal squamous cell carcinomas. Head and Neck-Journal for the Sciences and Specialties of the Head and Neck. 2016;38(9):1299-1309.

6. Bober SL, Reese JB, Barbera L, et al. How to ask and what to do: a guide for clinical inquiry and intervention regarding female sexual health after cancer. Current opinion in supportive and palliative care. 2016;10(1):44-54 PMID: 26716390, PMC4984532.

7. Bobrov E, Skobeleva N, Restifo D, et al. Targeted delivery of chemotherapy using HSP90 inhibitor drug conjugates is highly active against pancreatic cancer models. Oncotarget. 2016 PMID: 27779106.

8. Capo-chichi CD, Aguida B, Chabi NW, et al. Lamin A/C deficiency is an independent risk factor for cervical cancer. Cellular oncology (Dordrecht). 2016;39(1):59-68 PMID: 26537870.

9. Carlson RW, McClure JS. Financial Relationships With Industry Among National Comprehensive Cancer Network Guideline Authors. JAMA oncology. 2016 PMID: 27787555.

10. Chan JK, Java JJ, Fuh K, et al. The association between timing of initiation of adjuvant therapy and the survival of early stage ovarian cancer patients – An analysis of NRG oncology/gynecologic oncology group trials. Gynecologic oncology. 2016 PMID: 27771168.

11. Choi YB, Shembade N, Parvatiyar K, Balachandran S, Harhaj EW. TAX1BP1 restrains virus-induced apoptosis by facilitating Itch-mediated degradation of the mitochondrial adaptor MAVS. Molecular and cellular biology. 2016 PMID: 27736772.

12. Choueiri TK, Fishman MN, Escudier B, et al. Immunomodulatory Activity of Nivolumab in Metastatic Renal Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research. 2016 PMID: 27169994>

13. Churilla TM, Egleston B, Bleicher R, Dong Y, Meyer J, Anderson P. Disparities in the Local Management of Breast Cancer in the US according to Health Insurance Status. The breast journal. 2016 PMID: 27797159.

14. Churilla TM, Egleston BL, Murphy CT, et al. Erratum to: Patterns of multidisciplinary care in the management of non-metastatic invasive breast cancer in the United States Medicare patient. Breast cancer research and treatment. 2016 PMID: 27766452.

15. Clark PE, Spiess PE, Agarwal N, et al. NCCN Guidelines Insights: Bladder Cancer, Version 2.2016. Journal of the National Comprehensive Cancer Network : JNCCN. 2016;14(10):1213-1224 PMID: 27697976.

16. Daly MB, Pilarski R, Axilbund JE, et al. Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015. Journal of the National Comprehensive Cancer Network : JNCCN. 2016;14(2):153-162 PMID: 26850485.

17. Davis BM, Rall GF, Schnell MJ. Everything You Always Wanted to Know About Rabies Virus (But Were Afraid to Ask). Annual review of virology. 2015;2(1):451-471 PMID: 26958924.

18. Devarajan K, Cheung VCK. A Quasi-Likelihood Approach to Nonnegative Matrix Factorization. Neural Computation. 2016;28(8):1663-1693.

19. Doss M. Disavowing the ALARA concept in pediatric imaging. Pediatric radiology. 2016:1.

20. Duivenvoorden WC, Daneshmand S, Canter D, et al. Incidence, Characteristics and Implications of Thromboembolic Events in Patients with Muscle Invasive Urothelial Carcinoma of the Bladder Undergoing Neoadjuvant Chemotherapy. The Journal of urology. 2016 PMID: 27312316.

21. Duong-Ly KC, Devarajan K, Liang S, et al. Kinase Inhibitor Profiling Reveals Unexpected Opportunities to Inhibit Disease-Associated Mutant Kinases. Cell reports. 2016;14(4):772-781 PMID: 26776524, PMC4740242.

22. El-Deiry WS, Vijayvergia N, Xiu J, et al. Molecular profiling of 6,892 colorectal cancer samples suggests different possible treatment options specific to metastatic sites. Cancer biology & therapy. 2015;16(12):1726-1737 PMID: 26553611, PMC4847814.

23. Friedant AJ, Handorf EA, Su S, Scott WJ. Minimally Invasive versus Open Thymectomy for Thymic Malignancies: Systematic Review and Meta-Analysis. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2016;11(1):30-38 PMID: 26762737.

24. Gaponova AV, Nikonova AS, Deneka AY, et al. A novel HSP90 inhibitor-drug conjugate to SN38 is highly effective in small cell lung cancer. Clinical Cancer Research. 2016;22(20):5120-5129.

25. Geynisman DM, Handorf E, Wong YN, et al. Advanced small cell carcinoma of the bladder: clinical characteristics, treatment patterns and outcomes in 960 patients and comparison with urothelial carcinoma. Cancer medicine. 2016;5(2):192-199 PMID: 26679712, PMC4735777.

26. Gonzalez BD, Manne SL, Stapleton J, et al. Quality of life trajectories after diagnosis of gynecologic cancer: a theoretically based approach. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 2016 PMID: 27757706.

27. Gradishar WJ, Anderson BO, Balassanian R, et al. NCCN Guidelines Insights Breast Cancer, Version 1.2016. Journal of the National Comprehensive Cancer Network : JNCCN. 2015;13(12):1475-1485 PMID: 26656517.

28. Gregory KA. Easy as ABC: How Staff Nurses Transformed Unit Culture to Assess and Manage Delirium in the Intensive Care Unit. Critical care nurse. 2016;36(5):73-76 PMID: 27694361.

29. Guo J, Zinner R, Zaorsky NG, Guo W, Lu B. Systemic therapy for echinoderm microtubule-associated protein-like 4 anaplastic lymphoma kinase non-small cell lung cancer brain metastases. Journal of thoracic disease. 2016;8(9):E1028-e1031 PMID: 27747054.

30. Gupta S, Wang L, Kruger WD. Betaine supplementation is less effective than methionine restriction in correcting phenotypes of CBS deficient mice. Journal of inherited metabolic disease. 2016;39(1):39-46 PMID: 26231230, PMC4784539.

31. Guttmann DM, Li H, Sevak P, et al. The Impact of Adjuvant Therapy on Survival and Recurrence Patterns in Women With Early-Stage Uterine Carcinosarcoma: A Multi-institutional Study. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 2016;26(1):141-148 PMID: 26509850.

32. Hamdi Y, Soucy P, Kuchenbaeker KB, et al. Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3. Breast cancer research and treatment. 2016 PMID: 27796716.

33. Haughey BH, Sinha P, Kallogjeri D, et al. Pathology-based staging for HPV-positive squamous carcinoma of the oropharynx. Oral oncology. 2016;62:11-19.

34. Hossain NM, Chapuis AG, Walter RB. T-Cell Receptor-Engineered Cells for the Treatment of Hematologic Malignancies. Current Hematologic Malignancy Reports. 2016;11(4):311-317.

35. Hossain NM, Klumpp T, Ulicny J, et al. Donor Lymphocyte Infusion in Hematologic Malignancies–Good to be Fresh? Clinical lymphoma, myeloma & leukemia. 2016;16(2):111-115 PMID: 26632076.

36. Hudson SV, Ohman-Strickland PA, Bator A, et al. Breast and prostate cancer survivors’ experiences of patient-centered cancer follow-up care from primary care physicians and oncologists. Journal of Cancer Survivorship. 2016;10(5):906-914.

37. Hui SKA, Miller SM, Hazuda L, Engelman K, Ellerbeck EF. Novel Method for Recruiting Representative At-Risk Individuals into Cancer Prevention Trials: Online Health Risk Assessment in Employee Wellness Programs. Journal of Cancer Education. 2016;31(3):421-429.

38. Ingram JP, Brodsky IE, Balachandran S. Interferon-gamma in Salmonella pathogenesis: New tricks for an old dog. Cytokine. 2016 PMID: 27773552.

39. Jaffe EK. The Remarkable Character of Porphobilinogen Synthase. Accounts of chemical research. 2016 PMID: 27783504.

40. Jiang W, Dulaimi E, Devarajan K, et al. Immunohistochemistry Successfully Uncovers Intratumoral Heterogeneity and Widespread Co-Losses of Chromatin Regulators in Clear Cell Renal Cell Carcinoma. PloS one. 2016;11(10):e0164554 PMID: 27764136.

41. Jin C, Qin T, Barton MC, Jelinek J, Issa JP. Minimal role of base excision repair in TET-induced global DNA demethylation in HEK293T cells. Epigenetics. 2015;10(11):1006-1013 PMID: 26440216, PMC4844212.

42. Jin L, Price RA, Wang L, Meyer J, Fan JJ, Ma CM. Dosimetric and delivery efficiency investigation for treating hepatic lesions with a MLC-equipped robotic radiosurgery-radiotherapy combined system. Medical physics. 2016;43(2):727-733 PMID: 26843236.

43. Katz MHG, Shi Q, Ahmad SA, et al. Preoperative Modified FOLFIRINOX Treatment Followed by Capecitabine-Based Chemoradiation for Borderline Resectable Pancreatic Cancer Alliance for Clinical Trials in Oncology Trial A021101. Jama Surgery. 2016;151(8).
44. Kniazeva E, Hardy AN, Boukaidi SA, Woodruff TK, Jeruss JS, Shea LD. Primordial Follicle Transplantation within Designer Biomaterial Grafts Produce Live Births in a Mouse Infertility Model. Scientific reports. 2015;5:17709 PMID: 26633657, PMC4668556.

45. Kutikov A, Woo HH, Catto JW. Urology Tag Ontology Project: Standardizing Social Media Communication Descriptors. European urology. 2016;69(2):183-185 PMID: 26443429.

46. Langer CJ, Gadgeel SM, Borghaei H, et al. Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study. The Lancet Oncology. 2016 PMID: 27745820.

47. Lango MN, Handorf E, Arjmand E. The geographic distribution of the otolaryngology workforce in the United States. The Laryngoscope. 2016 PMID: 27774588.

48. Leachman BK, Galloway TJ. The Role for Radiation Therapy in the Management of Sarcoma. Surgical Clinics of North America. 2016;96(5):1127-1139.

49. Leichman L, Groshen S, O’Neil BH, et al. Phase II Study of Olaparib (AZD-2281) After Standard Systemic Therapies for Disseminated Colorectal Cancer. The oncologist. 2016;21(2):172-177 PMID: 26786262, PMC4746089.

50. Li P, Wong YN, Armstrong K, et al. Survival among patients with advanced renal cell carcinoma in the pretargeted versus targeted therapy eras. Cancer medicine. 2016;5(2):169-181 PMID: 26645975, PMC4735783.

51. Manne SL, Topham N, Kirstein L, et al. Attitudes and Decisional Conflict Regarding Breast Reconstruction Among Breast Cancer Patients. Cancer nursing. 2016;36(6):427-436 PMID: 26780376, PMC4947023.

52. Marks EI, Tan C, Zhang J, et al. Regorafenib with a fluoropyrimidine for metastatic colorectal cancer after progression on multiple 5-FU-containing combination therapies and regorafenib monotherapy. Cancer biology & therapy. 2015;16(12):1710-1719 PMID: 26561209, PMC4847811.

53. McComb BL, Munden RF, Duan FH, Jain AA, Tuite C, Chiles C. Normative reference values of thoracic aortic diameter in American College of Radiology Imaging Network (ACRIN 6654) arm of National Lung Screening Trial. Clinical Imaging. 2016;40(5):936-943.

54. Michael JV, Wurtzel JG, Goldfinger LE. Inhibition of Galectin-1 Sensitizes HRAS-driven Tumor Growth to Rapamycin Treatment. Anticancer research. 2016;36(10):5053-5061 PMID: 27798864.

55. Mizukami T, Sakuma Y, Maki K. Statistical Mechanical Model for pH-Induced Protein Folding: Application to Apomyoglobin. Journal of Physical Chemistry B. 2016;120(34):8970-8986.

56. Mohler JL, Armstrong AJ, Bahnson RR, et al. Prostate Cancer, Version 1.2016. Journal of the National Comprehensive Cancer Network : JNCCN. 2016;14(1):19-30 PMID: 26733552.

57. Monteith JA, Mellert H, Sammons MA, et al. A rare DNA contact mutation in cancer confers p53 gain-of-function and tumor cell survival via TNFAIP8 induction. Molecular Oncology. 2016;10(8):1207-1220.

58. Necchi A, Sonpavde G, Lo Vullo S, et al. Nomogram-based Prediction of Overall Survival in Patients with Metastatic Urothelial Carcinoma Receiving First-line Platinum-based Chemotherapy: Retrospective International Study of Invasive/Advanced Cancer of the Urothelium (RISC). European urology. 2016 PMID: 27726966.

59. Peng S, Zhou P, He W, Liao M, Chen L, Ma CM. Treatment of hepatic tumors by thermal versus mechanical effects of pulsed high intensity focused ultrasound in vivo. Physics in Medicine and Biology. 2016;61(18):6754-6769.

60. Ramakodi MP, Kulathinal RJ, Chung Y, Serebriiskii I, Liu JC, Ragin CC. Ancestral-derived effects on the mutational landscape of laryngeal cancer. Genomics. 2016;107(2-3):76-82 PMID: 26721311, PMC4761303.

61. Ream E, Gargaro G, Barsevick A, Richardson A. Management of cancer-related fatigue during chemotherapy through telephone motivational interviewing: modeling and randomized exploratory trial. Patient education and counseling. 2015;98(2):199-206 PMID: 25468398.

62. Reese JB, Haythornthwaite JA. Importance of sexuality in colorectal cancer: predictors, changes, and response to an intimacy enhancement intervention. Supportive Care in Cancer. 2016;24(10):4309-4317.

63. Rice TW, Apperson-Hansen C, DiPaola LM, et al. Worldwide Esophageal Cancer Collaboration: clinical staging data. Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus. 2016;29(7):707-714 PMID: 27731549.

64. Rice TW, Chen LQ, Hofstetter WL, et al. Worldwide Esophageal Cancer Collaboration: pathologic staging data. Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus. 2016;29(7):724-733 PMID: 27731547.

65. Rice TW, Lerut TE, Orringer MB, et al. Worldwide Esophageal Cancer Collaboration: neoadjuvant pathologic staging data. Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus. 2016;29(7):715-723 PMID: 27731548.

66. Ristau BT, Smaldone MC. Difference of opinion – Radical prostatectomy in metastatic prostate cancer: is there enough evidence? | Opinion: No. International braz j urol : official journal of the Brazilian Society of Urology. 2016;42(5):880-882 PMID: 27716457.

67. Russo J. Reproductive history and breast cancer prevention. Hormone Molecular Biology and Clinical Investigation. 2016;27(1):3-10.

68. Scharpf J, Tuttle M, Wong R, et al. Comprehensive management of recurrent thyroid cancer: An American Head and Neck Society consensus statement: AHNS consensus statement. Head & neck. 2016 PMID: 27717219.

69. Schuetze SM, Bolejack V, Choy E, et al. Phase 2 study of dasatinib in patients with alveolar soft part sarcoma, chondrosarcoma, chordoma, epithelioid sarcoma, or solitary fibrous tumor. Cancer. 2016 PMID: 27696380.

70. Shah JJ, Jakubowiak AJ, O’Connor OA, et al. Phase I Study of the Novel Investigational NEDD8-Activating Enzyme Inhibitor Pevonedistat (MLN4924) in Patients with Relapsed/Refractory Multiple Myeloma or Lymphoma. Clinical cancer research : an official journal of the American Association for Cancer Research. 2016;22(1):34-43 PMID: 26561559.

71. Shemesh A, Kugel A, Steiner N, et al. NKp44 and NKp30 splice variant profiles in decidua and tumor tissues: a comparative viewpoint. Oncotarget. 2016 PMID: 27765926.

72. Silvestri V, Barrowdale D, Mulligan AM, et al. Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2. Breast cancer research : BCR. 2016;18(1):15 PMID: 26857456, PMC4746828.

73. Smaglo BG, Tesfaye A, Halfdanarson TR, et al. Comprehensive multiplatform biomarker analysis of 199 anal squamous cell carcinomas. Oncotarget. 2015;6(41):43594-43604 PMID: 26498363, PMC4791253.

74. Smith MR, Hong F, Li H, et al. Mantle cell lymphoma initial therapy with abbreviated R-CHOP followed by 90Yibritumomab tiuxetan: Ten year follow-up of the phase 2 ECOG-ACRIN study E1499. Leukemia. 2016 PMID: 27780968.

75. Speen AM, Kim HH, Bauer RN, et al. Ozone-derived Oxysterols Affect Liver X Receptor (LXR) Signaling: A Potential Role for Lipid-Protein Adducts. The Journal of biological chemistry. 2016 PMID: 27703007.

76. Stinchcombe TE, Borghaei H, Barker SS, Treat JA, Obasaju C. Pemetrexed With Platinum Combination as a Backbone for Targeted Therapy in Non-Small-Cell Lung Cancer. Clinical lung cancer. 2016;17(1):1-9 PMID: 26340853.

77. Studitsky VM, Nizovtseva EV, Shaytan AK, Luse DS. Nucleosomal Barrier to Transcription: Structural Determinants and Changes in Chromatin Structure. Biochemistry & molecular biology journal. 2016;2(2) PMID: 27754494, PMC5041593.

78. Swisher SG, Moughan J, Komaki RU, et al. Final Results of NRG Oncology RTOG 0246: An Organ-Preserving Selective Resection Strategy in Esophageal Cancer Patients Treated with Definitive Chemoradiation. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2016 PMID: 27729298.

79. Tanaka K, Whelan KA, Chandramouleeswaran PM, et al. ALDH2 modulates autophagy flux to regulate acetaldehyde-mediated toxicity thresholds. American Journal of Cancer Research. 2016;6(4):781-796.

80. Terry MB, Phillips KA, Daly MB, et al. Cohort Profile: The Breast Cancer Prospective Family Study Cohort (ProF-SC). International Journal of Epidemiology. 2016;45(3):683-692.

81. Thapa RJ, Ingram JP, Ragan KB, et al. DAI Senses Influenza A Virus Genomic RNA and Activates RIPK3-Dependent Cell Death. Cell host & microbe. 2016 PMID: 27746097.
82. Thomas C, Ji Y, Lodhi N, et al. Non-NAD-Like poly(ADP-Ribose) Polymerase-1 Inhibitors effectively Eliminate Cancer in vivo. EBioMedicine. 2016 PMID: 27727003.

83. Travis WD, Asamura H, Bankier AA, et al. The IASLC Lung Cancer Staging Project: Proposals for Coding T Categories for Subsolid Nodules and Assessment of Tumor Size in Part-Solid Tumors in the Forthcoming Eighth Edition of the TNM Classification of Lung Cancer. Journal of Thoracic Oncology. 2016;11(8):1204-1223.

84. Tsueng G, Good BM, Ping PP, et al. Gene Wild Reviews-Raising the quality and accessibility of information about the human genome. Gene. 2016;592(2):235-2.

85. Valieva ME, Feofanov AV, Studitsky VM. Histone chaperones: Variety and functions. Moscow University Biological Sciences Bulletin. 2016;71(3):165-169.

86. Vijayvergia N, Cohen SJ. Personalized medicine in sporadic pancreatic cancer without homologous recombination-deficiency: are we any closer? Journal of gastrointestinal oncology. 2016;7(5):727-737 PMID: 27747087.

87. Villamar Cruz O, Prudnikova TY, Araiza-Olivera D, et al. Reduced PAK1 activity sensitizes FA/BRCA-proficient breast cancer cells to PARP inhibition. Oncotarget. 2016 PMID: 27740936.

88. Wang EH, Yu JB, Abouassally R, et al. Disparities in Treatment of Patients With High-risk Prostate Cancer: Results From a Population-based Cohort. Urology. 2016;95:88-94.

89. Wang M, Devarajan K, Singal AG, et al. The Doylestown Algorithm: A Test to Improve the Performance of AFP in the Detection of Hepatocellular Carcinoma. Cancer prevention research (Philadelphia, Pa). 2016;9(2):172-179 PMID: 26712941, PMC4740237.

90. Weinberg Md DS, Barkun A, Turner BJ. Colorectal Cancer Screening in the United States: What Is the Best FIT? Annals of internal medicine. 2016 PMID: 27776358.

91. Wells G, Chernoff J, Gilligan JP, Krause DS. Does salmon calcitonin cause cancer? A review and meta-analysis. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 2016;27(1):13-19 PMID: 26438308, PMC4715844.

92. Wickstrom L, Deng N, He P, et al. Parameterization of an effective potential for protein-ligand binding from host-guest affinity data. Journal of molecular recognition : JMR. 2016;29(1):10-21 PMID: 26256816, PMC4715590.

93. Winn JS, Baker MG, Fanous IS, Slack-Davis JK, Atkins KA, Dillon PM. Lobular Breast Cancer and Abdominal Metastases: A Retrospective Review and Impact on Survival. Oncology. 2016;91(3):135-142.

94. Wong YN, Roach N, Meropol NJ. Addressing Patients’ Priorities as a Strategy to Improve Value. The oncologist. 2016 PMID: 27742905.

95. Xiao C, Zhang Q, Nguyen-Tan PF, et al. Quality of Life and Performance Status From a Substudy Conducted Within a Prospective Phase 3 Randomized Trial of Concurrent Standard Radiation Versus Accelerated Radiation Plus Cisplatin for Locally Advanced Head and Neck Carcinoma: NRG Oncology RTOG 0129. International journal of radiation oncology, biology, physics. 2016 PMID: 27727063.

96. Zahid MF, Khan N, Hashmi SK, Kizilbash SH, Barta SK. Central nervous system prophylaxis in diffuse large B-cell lymphoma. European Journal of Haematology. 2016;97(2):108-120.

97. Zaorsky NG, Churilla TM, Ruth K, et al. Men’s health supplement use and outcomes in men receiving definitive intensity-modulated radiation therapy for localized prostate cancer. The American journal of clinical nutrition. 2016 PMID: 27797706.

98. Zaorsky NG, Shaikh T, Ruth K, et al. Prostate Cancer Patients With Unmanaged Diabetes or Receiving Insulin Experience Inferior Outcomes and Toxicities After Treatment With Radiation Therapy. Clinical genitourinary cancer. 2016 PMID: 27789181.

99. Zhao S, Torres A, Henry RA, et al. ATP-Citrate Lyase Controls a Glucose-to-Acetate Metabolic Switch. Cell reports. 2016;17(4):1037-1052 PMID: 27760311.

100. Zhou Z, Rademaker AW, Gordon LI, et al. High Body Mass Index in Elderly Patients With DLBCL Treated With Rituximab-Containing Therapy Compensates for Negative Impact of Male Sex. Journal of the National Comprehensive Cancer Network : JNCCN. 2016;14(10):1274-1281 PMID: 27697981.

101. Zibelman M, Plimack ER. Systemic therapy for bladder cancer finally comes into a new age. Future Oncology. 2016;12(19):2227-2242.

102. Zijoo R, Olszanski AJ, Weinberg DS. Biomarkers and stage II colorectal cancer therapy. Translational Cancer Research. 2016;5:S84-S86.

103. Zou ZW, Ma C, Medoro L, et al. LncRNA ANRIL is up-regulated in nasopharyngeal carcinoma and promotes the cancer progression via increasing proliferation, reprograming cell glucose metabolism and inducing sidepopulation stem-like cancer cells. Oncotarget. 2016;7(38):61741-61754.

Staff Publications: September 2016

1.    Adams DL, Alpaugh RK, Tsai S, Tang CM, Stefansson S. Multi-Phenotypic subtyping of circulating tumor cells using sequential fluorescent quenching and restaining. Sci Rep. 2016;6:33488. PMID: 27647345 PMCID: PMC5028835.

2.    Allen JE, Kline CL, Prabhu VV, et al. Discovery and clinical introduction of first-in-class imipridone ONC201. Oncotarget. 2016 PMID: 27602582.

3.    Atretkhany KN, Drutskaya MS, Nedospasov SA, Grivennikov SI, Kuprash DV. Chemokines, cytokines and exosomes help tumors to shape inflammatory
microenvironment. Pharmacol Ther. 2016 PMID: 27613100.

4.    Avkshtol V, Doss M, Devarajan K, et al. Using Metabolic Tumor Velocity to Preoperatively Predict the Neoadjuvant Rectal Score. Int J Radiat Oncol Biol Phys. 2016;96(2S):E206-E207. PMID: 27674061.

5.    Bass SB, Wolak C, Greener J, et al. Using perceptual mapping methods to understand gender differences in perceived barriers and benefits of clinical research participation in urban minority HIV+ patients. AIDS Care. 2016;28(4):528-536. PMID: 26572215.

6.    Bassi DE, Zhang J, Renner C, Klein-Szanto AJ. Targeting proprotein convertases in furin-rich lung cancer cells results in decreased in vitro and in vivo growth. Mol Carcinog. 2016 PMID: 27584082.

7.    Bauman JR, Piotrowska Z, Muzikansky A, et al. End-of-Life Care in Patients with Metastatic Lung Cancer Harboring Epidermal Growth Factor Receptor Mutations. J Palliat Med. 2016 PMID: 27626514.

8.    Bellacosa A, Chernoff J, Testa JR. Alfred G. Knudson (1922-2016) Obituary. Cell. 2016;166(4):785-786. WOS:000382258700001.

9.    Borghaei H, Brahmer J, Horn L, et al. P2.35: Nivolumab vs Docetaxel in Advanced NSCLC: CheckMate 017/057 2-Y Update and Exploratory Cytokine Profile Analysis: Track: Immunotherapy. J Thorac Oncol. 2016;11(10S):S237-S238. PMID: 27676569.

10.    Buscariollo D, Cronin A, Bleicher RJ, et al. Association Between the 21-Gene Recurrence Score and Isolated Local-Regional Recurrence in Hormone Receptor-Positive Breast Cancer. Int J Radiat Oncol Biol Phys. 2016;96(2S):E13. PMID: 27673854.

11.    Cagney DN, Van Dijk KR, Horvath MC, et al. Cortical Structural Changes in Patients Receiving Whole-Brain Radiation Therapy (WBRT). Int J Radiat Oncol Biol Phys. 2016;96(2S):E71-E72. PMID: 27675426.

12.    Chen L, Cvetkovic D, Wang B, Gupta R, Ma CM. Management of Prostate Cancer Using Magnetic Resonance Guided Pulsed Focused Ultrasound-Mediated Targeted Chemotherapeutic Agent Delivery. Int J Radiat Oncol Biol Phys. 2016;96(2S):E260. PMID: 27674203.

13.    Chow LQ, Haddad R, Gupta S, et al. Antitumor Activity of Pembrolizumab in Biomarker-Unselected Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results From the Phase Ib KEYNOTE-012 Expansion Cohort. J Clin Oncol. 2016 PMID: 27646946.

14.    Churilla TM, Egleston BL, Murphy CT, et al. Patterns of multidisciplinary care in the management of non-metastatic invasive breast cancer in the United States Medicare patient. Breast Cancer Res Treat. 2016 PMID: 27640196.

15.    Churilla TM, Handorf E, Soffietti R, et al. Does Whole-Brain Radiation Therapy for Oligometastatic Brain Metastases Translate Into a Survival Benefit for Patients With a Limited Competing Risk From Extracranial Disease? A Secondary Analysis of EORTC 22952-26001. Int J Radiat Oncol Biol Phys. 2016;96(2S):S56-S57. PMID: 27675960.

16.    Corradetti C, Jog NR, Gallucci S, Madaio M, Balachandran S, Caricchio R. Immune-Mediated Nephropathy and Systemic Autoimmunity in Mice Does Not Require Receptor Interacting Protein Kinase 3 (RIPK3). PLoS One. 2016;11(9):e0163611. PMID: 27669412.

17.    Dhawan I, Li T, Fundakowski C, et al. Is a Focally Positive Margin During Glossectomy an Indication for Adjuvant Radiation If the Margin Is Re-Resected During the Same Operation? Int J Radiat Oncol Biol Phys. 2016;96(2S):E349-E350. PMID: 27674448.

18.    Dong Y, Li T, Churilla TM, et al. Long-Term Toxicities in Survivors of Radiation Treatment for Head and Neck Cancer. Int J Radiat Oncol Biol Phys. 2016;96(2S):E394. PMID: 27674573.

19.    Dziemianowicz M, Murphy CT, Devarajan K, et al. Evaluating the Impact of Node-Specific Growth in Patients With Node-Positive Oropharyngeal Cancer. Int J Radiat Oncol Biol Phys. 2016;96(2S):E368-E369. PMID: 27674500.

20.    El-Deiry WS. p21(WAF1) Mediates Cell-Cycle Inhibition, Relevant to Cancer Suppression and Therapy. Cancer Res. 2016;76(18):5189-5191. PMID: 27635040 PMCID: PMC5028108.
21.    Escalante DA, Wang H, Fundakowski CE. Fusion proteins in head and neck neoplasms: Clinical implications, genetics, and future directions for targeting. Cancer Biol Ther. 2016:1-8. PMID: 27636353.

22.    Fareed MM, Churilla TM, Galloway TJ. Impact of Primary Tumor-Specific Growth Rate on Treatment Failure for Non-Oropharyngeal Head and Neck Cancers. Int J Radiat Oncol Biol Phys. 2016;96(2S):E390. PMID: 27674561.

23.    Feitelson MA, Arzumanyan A, Kulathinal RJ, et al. Sustained proliferation in cancer: Mechanisms and novel therapeutic targets. Semin Cancer Biol. 2015;35 Suppl:S25-54. PMID: 25892662 PMCID: PMC4898971.

24.    Flynn KE, Lin L, Bruner DW, et al. Sexual Satisfaction and the Importance of Sexual Health to Quality of Life Throughout the Life Course of U.S. Adults. J Sex Med. 2016 PMID: 27671968.

25.    Gray PN, Vuong H, Tsai P, et al. TumorNext: A comprehensive tumor profiling assay that incorporates high resolution copy number analysis and germline status to improve testing accuracy. Oncotarget. 2016 PMID: 27626691.

26.    Hawken SR, Krishnan NK, Ambani SN, et al. Effect of delayed resection after initial surveillance and tumor growth rate on final surgical pathology in patients with small renal masses (SRMs). Urol Oncol. 2016 PMID: 27687544.

27.    Heckman CJ, Kloss JD, Feskanich D, Culnan E, Schernhammer ES. Associations among rotating night shift work, sleep and skin cancer in Nurses’ Health Study II participants. Occup Environ Med. 2016 PMID: 27663986.

28.    Hoffman JP, Reddy SS. Is It Time for Total Neoadjuvant Therapy for Patients With Resectable Pancreatic Adenocarcinoma? J Oncol Pract. 2016;12(9):780-781. PMID: 27621327.

29.    Horwitz SM, Zelenetz AD, Gordon LI, et al. NCCN Guidelines Insights: Non-Hodgkin’s Lymphomas, Version 3.2016. J Natl Compr Canc Netw. 2016;14(9):1067-1079. PMID: 27587620.

30.    Hu B, Arpag S, Zhang X, et al. Tuning PAK Activity to Rescue Abnormal Myelin Permeability in HNPP. PLoS Genet. 2016;12(9):e1006290. PMID: 27583434 PMCID: PMC5008806.

31.    Johnson SB, Soulos PR, Shafman TD, et al. Patient-Reported Quality of Life After Stereotactic Body Radiation Therapy Versus Moderate Hypofractionation for Clinically Localized Prostate Cancer. Int J Radiat Oncol Biol Phys. 2016;96(2S):E242. PMID: 27674157.

32.    Kachnic LA, Moughan J, Suntharalingam M, et al. Patient-Reported Outcomes (PROs) in NRG Oncology/RTOG 0436: A Phase 3 Trial Evaluating the Addition of Cetuximab to Paclitaxel, Cisplatin, and Radiation for Esophageal Cancer Treated Without Surgery. Int J Radiat Oncol Biol Phys. 2016;96(2S):S31. PMID: 27675900.

33.    Kelly KR, Gabrail N, Weitman S, et al. Phase 1 study evaluating the safety and pharmacokinetics of pralatrexate in relapsed/refractory advanced solid tumors and lymphoma patients with mild, moderate, and severe renal impairment. Cancer Chemother Pharmacol. 2016 PMID: 27638045.

34.    Kishan AU, Shaikh T, Wang J, et al. Clinical Outcomes for Patients With Gleason Score 9-10 Prostate Adenocarcinoma Treated With Radiation Therapy or Radical Prostatectomy: A Comparative Analysis. Int J Radiat Oncol Biol Phys. 2016;96(2S):E229. PMID: 27674120.

35.    Koutrouli N, Anagnostopoulos F, Tsikkinis A, Papastylianou D, Lepore S. Psychometric properties of the Greek version of the Social Constraints Scale in a sample of women with breast cancer. Women Health. 2016;56(4):413-427. PMID: 26496047.

36.    Kurland BF, Egleston BL. For Health-Related Quality of Life and Other Longitudinal Data, Analysis Should Distinguish Between Truncation by Death and Data Missing Because of Nonresponse. J Clin Oncol. 2016 PMID: 27601541.

37.    Lawrenson K, Kar S, McCue K, et al. Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus. Nat Commun. 2016;7:12675. PMID: 27601076 PMCID: PMC5023955.

38.    Leachman BK, Shaikh T, Li T, Anderson PR. Association Between Body Mass Index and Treatment Outcomes in Women Undergoing Breast Conservation: An Analysis of 3850 Women. Int J Radiat Oncol Biol Phys. 2016;96(2S):E59. PMID: 27675097.

39.    Ma CM, Eldib A, Chibani O, Mora G, Li J, Chen L. Exploring the Dosimetric Advantages of Cobalt Beams for Lung Cancer Stereotactic Body Radiation Therapy. Int J Radiat Oncol Biol Phys. 2016;96(2S):E655-E656. PMID: 27675277.

40.    Maluchenko NV, Chang HW, Kozinova MT, et al. [Inhibiting the pro-tumor and transcription factor FACT: Mechanisms]. Mol Biol (Mosk). 2016;50(4):599-610. PMID: 27668600.

41.    Maluchenko NV, Chang HW, Kozinova MT, et al. Inhibiting the pro-tumor and transcription factor FACT: Mechanisms. Molecular Biology. 2016;50(4):532-541.

42.    Merza H, Sarkar R. Solitary extraosseous plasmacytoma. Clin Case Rep. 2016;4(9):851-854. PMID: 27648261 PMCID: PMC5018587.

43.    Meyer JE, Galloway TJ, Ruth K, et al. Efficacy of Pulsed Low-Dose-Rate Reirradiation: Results From a Phase 1 Clinical Trial. Int J Radiat Oncol Biol Phys. 2016;96(2S):S147. PMID: 27675641.

44.    Meyer LA, Cronin AM, Sun CC, et al. Use and Effectiveness of Neoadjuvant Chemotherapy for Treatment of Ovarian Cancer. J Clin Oncol. 2016 PMID: 27601552.

45.    Miron B, Ristau BT, Tomaszewski JJ, et al. Biology is Destiny: A Case of Adrenocortical Carcinoma Diagnosed and Resected at Inception in a Patient Under Close Surveillance for Lung Cancer. Urol Case Rep. 2016;9:9-11. PMID: 27617213 PMCID: PMC5011172.

46.    Morgan RJ, Armstrong DK, Alvarez RD, et al. Ovarian Cancer, Version 1.2016. Journal of the National Comprehensive Cancer Network. 2016;14(9):1134-1163. WOS:000382903900009.

47.    Murphy CT, Handorf E, Sigurdson ER, et al. Assessment of National Practice Patterns of Radiation Therapy Use after Neoadjuvant Chemotherapy for Breast Cancer. Int J Radiat Oncol Biol Phys. 2016;96(2S):E51-E52. PMID: 27674882.

48.    Paly J, Shaikh T, Scott WJ, et al. Comparative Effectiveness of Standard Versus High-Dose Neoadjuvant Chemoradiation Followed by Surgery for Locally Advanced Non-Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys. 2016;96(2S):S200-S201. PMID: 27675778.

49.    Peri S, Caretti E, Tricarico R, et al. Haploinsufficiency in tumor predisposition syndromes: altered genomic transcription in morphologically normal cells heterozygous for VHL or TSC mutation. Oncotarget. 2016 PMID: 27682873.

50.    Perrapato SD, Gore J, du Plessis M, et al. A Genomic Classifier Impacts Treatment Decision Making Among Patients With Biochemical Recurrence After Radical Prostatectomy: Results From the Multicenter Prospective PRO-IMPACT Study. Int J Radiat Oncol Biol Phys. 2016;96(2S):E222-E223. PMID: 27674104.

51.    Pishvaian M, Morse MA, McDevitt J, et al. Phase 1 Dose Escalation Study of MEDI-565, a Bispecific T-Cell Engager that Targets Human Carcinoembryonic Antigen, in Patients With Advanced Gastrointestinal Adenocarcinomas. Clin Colorectal Cancer. 2016 PMID: 27591895.

52.    Rahman R, Catalano PJ, Arvold ND, et al. Chemoradiation-Related Lymphopenia Is Common Among Glioblastoma Patients and Is Associated With Worse Progression-Free and Overall Survival. Int J Radiat Oncol Biol Phys. 2016;96(2S):E123. PMID: 27673836.

53.    Rall G, Knoll LJ. Development of Complex Models to Study Co- and Polymicrobial Infections and Diseases. PLoS Pathog. 2016;12(9):e1005858. PMID: 27607188 PMCID: PMC5015861.

54.    Ramos JD, Casey MF, Bamias A, et al. The Khorana Score in Predicting Venous Thromboembolism for Patients With Metastatic Urothelial Carcinoma and Variant Histology Treated With Chemotherapy. Clin Appl Thromb Hemost. 2016 PMID: 27637910.

55.    Reese JB, Porter LS, Casale KE, et al. Adapting a couple-based intimacy enhancement intervention to breast cancer: A developmental study. Health Psychol. 2016;35(10):1085-1096. PMID: 27657981 PMCID: PMC5034713.

56.    Ristau BT, Geynisman DM. Patient-reported and Cost-effectiveness Outcomes Are Key to Determining the Optimal Therapeutic Sequence for Patients with Metastatic Renal Cell Carcinoma. Eur Urol. 2016 PMID: 27638095.

57.    Shaikh T, Churilla TM, Murphy CT, Hallman MA, Scott WJ, Meyer JE. Comparative Effectiveness of Lobectomy, Sublobar Resection, and Stereotactic Body Radiation Therapy for Clinical Stage I Non-Small Cell Lung Cancer: A Propensity-Matched Analysis. Int J Radiat Oncol Biol Phys. 2016;96(2S):E451-E452. PMID: 27674728.

58.    Shaikh T, Churilla TM, Zaorsky NG, et al. Postmastectomy Radiation Therapy in Women With ypN0-N3 Breast Cancer. Int J Radiat Oncol Biol Phys. 2016;96(2S):E27. PMID: 27674227.

59.    Shaikh T, Ruth K, Devarajan K, et al. Dosimetric and Clinical Predictors of Long-Term Toxicity in Patients Undergoing Hypofractionated Prostate Radiation Therapy: Results From a Randomized Phase 3 Trial. Int J Radiat Oncol Biol Phys. 2016;96(2S):S123. PMID: 27675581.

60.    Sisti DA, Ramamurthy C. From alienism to ACOs: Integrating psychiatry, again. Psychiatric Services. 2016;67(4):372-374.

61.    Smith TM, McGovern K, Mojica A, Bhattacharya A. Hepatitis B virus immunity 15 years after vaccination: Implications for young adults. Consultant. 2016;56(9):796-798.

62.    Solomos AC, O’Regan KJ, Rall GF. CD4+ T cells require either B cells or CD8+ T cells to control spread and pathogenesis of a neurotropic infection. Virology. 2016;499:196-202. PMID: 27677156.

63.    Thomas C, Movva S. Eribulin in the management of inoperable soft-tissue sarcoma: patient selection and survival. Onco Targets Ther. 2016;9:5619-5627. PMID: 27672333 PMCID: PMC5024770.

64.    Tricarico R, Kasela M, Mareni C, et al. Assessment of the InSiGHT Interpretation Criteria for the Clinical Classification of 24 MLH1 and MSH2 Gene Variants. Hum Mutat. 2016 PMID: 27629256.

65.    Wang EH, Abouassaly R, Yu JB, et al. Disparities in Access and Treatment of Patients With High-Risk Prostate Cancer: Results From a Population-Based Cohort. Int J Radiat Oncol Biol Phys. 2016;96(2S):E258. PMID: 27674195.

66.    Wang Y, Krais JJ, Bernhardy AJ, et al. RING domain-deficient BRCA1 promotes PARP inhibitor and platinum resistance. J Clin Invest. 2016;126(8):3145-3157. PMID: 27454289 PMCID: PMC4966309.

67.    Yao M, Zhang Q, Woods CR, et al. Intensity Modulated Radiation Therapy Versus 3-Dimensional Conformal Radiation Therapy in Head and Neck Squamous Cell Carcinoma: A Pooled Analysis of NRG Oncology/RTOG 0129 and 0522. Int J Radiat Oncol Biol Phys. 2016;96(2S):S116-S117. PMID: 27675562.

68.    Yoon S, Shaikh T, Ross EA, et al. Patterns and Predictors of Failure Following Definitive Chemoradiation for Locally Advanced Non-Small Cell Lung Cancer (NSCLC). Int J Radiat Oncol Biol Phys. 2016;96(2S):E477-E478. PMID: 27674796.

69.    Yu J, Gong Y, Yuan L, et al. Investigation Into the Feasibility of Having Uniform Compliance Dosimetric Criteria Across Radiation Therapy Treatment Modalities for NRG Oncology/RTOG 0938 by Using Machine Learning. Int J Radiat Oncol Biol Phys. 2016;96(2S):E230-E231. PMID: 27674126.

70.    Zaorsky NG, Handorf E, Horwitz EM, Hallman MA, Smaldone MC. Pretreatment Predictors of Receiving Adjuvant Radiation Therapy for Prostate Cancer. Int J Radiat Oncol Biol Phys. 2016;96(2S):E280. PMID: 27674259.

71.    Zaorsky NG, Ricco A, Churilla TM, Horwitz EM, Den RB. Applying ASTRO APEx Guidelines and RO-ILS to Medical Malpractice in Radiation Oncology. Int J Radiat Oncol Biol Phys. 2016;96(2S):E540. PMID: 27674964.

72.    Zhang Y, Xie J, Wang J, et al. Clinicopathological and Prognostic Analysis of Neuroendocrine Carcinoma of the Colorectum. Adv Clin Exp Med. 2016;25(4):719-724. PMID: 27629846.

73.    Zijoo R, von Mehren M. Efficacy of trabectedin for the treatment of liposarcoma. Expert Opin Pharmacother. 2016;17(14):1953-1962. PMID: 27615729.